Venture Certified
| 기술평가보증기업(기금) | 2020-11-11 ~ 2022-11-10 | 20200114608 | 2020-11-11 |
| 벤처투자유형 | 2023-04-19 ~ 2026-04-18 | 20230420010016 | 2020-11-11 |
Revenue CAGR +294.2%
| Item | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 19.5B | 4.6B | 1.3B |
| Operating Profit | -3.3B | -3.4B | -1.1B |
| Net Profit | -0.6B | -1.7B | -0.7B |
| Total Assets | 25.1B | 6.3B | 0.7B |
| Total Liabilities | 23.9B | 4.5B | 0.1B |
| Total Equity | 1.2B | 1.9B | 0.6B |
Debt Ratio 1932.0%: Exceeds 400%, financial soundness risk
Operating Loss: Op. profit -3B
3 Consecutive Years of Net Loss
Debt Ratio Surge (+1691pp YoY)
▲ 566.2%
▼ 47.3%
▲ 79.2%
▲ 1381.6%
▲ 51.7%
| Name | Position | Role |
|---|---|---|
| 김경태 | 대표이사 | 대표 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
1 Additional Data Sources
{
"address": "대구광역시 북구",
"ceo_name": "김경태",
"certificate": [
{
"cert_number": "20200114608",
"changes": "",
"disclosure_date": "2020-11-11",
"first_cert_date": "2020-11-11",
"no": "1",
"type": "기술평가보증기업(기금)",
"valid_period": "2020-11-11 ~ 2022-11-10"
},
{
"cert_number": "20230420010016",
"changes": "",
"disclosure_date": "2023-04-20",
"first_cert_date": "2020-11-11",
"no": "2",
"type": "벤처투자유형",
"valid_period": "2023-04-19 ~ 2026-04-18"
}
],
"company_name": "(주)서지오젠",
"corp_no": "170111-*******",
"financials": {
"2022": {
"capital_stock": 160000000,
"cost_of_sales": 76629000,
"current_assets": 34027000,
"current_liabilities": 11612000,
"gross_profit": 49184000,
"net_income": -67688000,
"net_income_bs": -67892000,
"non_current_assets": 36680000,
"non_current_liabilities": 0,
"non_operating_expenses": 35377000,
"non_operating_income": 81081000,
"operating_profit": -113392000,
"revenue": 125813000,
"sga_expenses": 162576000,
"total_assets": 70707000,
"total_equity": 59095000,
"total_liabilities": 11612000
},
"2023": {
"capital_stock": 181819000,
"cost_of_sales": 437979000,
"current_assets": 603684000,
"current_liabilities": 439108000,
"gross_profit": 23109000,
"net_income": -173566000,
"net_income_bs": -173566000,
"non_current_assets": 29281000,
"non_current_liabilities": 8323000,
"non_operating_expenses": 0,
"non_operating_income": 163411000,
"operating_profit": -336977000,
"revenue": 461088000,
"sga_expenses": 360086000,
"total_assets": 632965000,
"total_equity": 185534000,
"total_liabilities": 447431000
},
"2024": {
"capital_stock": 181819000,
"cost_of_sales": 1803254000,
"current_assets": 2360860000,
"current_liabilities": 2364970000,
"gross_profit": 151680000,
"net_income": -62039000,
"net_income_bs": -62039000,
"non_current_assets": 148576000,
"non_current_liabilities": 20971000,
"non_operating_expenses": 2058000,
"non_operating_income": 271673000,
"operating_profit": -331654000,
"revenue": 1954934000,
"sga_expenses": 483334000,
"total_assets": 2509436000,
"total_equity": 123495000,
"total_liabilities": 2385941000
}
},
"industry": "그 외 기타 의료용 기기 제조업",
"investment": [
{
"amount": "100,000,000",
"changes": "100,000,000",
"date": "2023-02-09"
},
{
"amount": "200,000,000",
"changes": "200,000,000",
"date": "2023-02-09"
}
],
"main_products": "의료기기",
"phone": "010-8789-****",
"years": [
2024,
2023,
2022
]
}Data Quality: 8/10 | Primary Source: Venture System | Section Coverage: 7/8
| Section | Source: | Status |
|---|---|---|
| Basic Info | Public Data | Collected |
| Financial Statements | Venture System | Collected |
| Investment Metrics | Venture System | Collected |
| Officers | Public Data | Collected |
| Employment | Not Collected | Not Collected |
| Certifications | Public Data | Collected |
| Patents | KIPRIS | Collected |
| Procurement | G2B Procurement | Collected |
| API | Collected | Status |
|---|---|---|
| G2B Procurement | 2026-02-25 | Collected |
| KIPRIS Patents | 2026-02-25 | Collected |
| Employment Insurance | 2026-02-25 | Collected |
| HomeTax Business | 2026-02-25 | Collected |
| Cert. Info | 2026-02-25 | Collected |
| Venture System Detail | 2026-02-25 | Collected |